NadA, a novel vaccine candidate of Neisseria meningitidis - Wikidata - wikimedia - TriplyDB

NadA, a novel vaccine candidate of Neisseria meningitidis

NadA, a novel vaccine candidate of Neisseria meningitidis

http://www.wikidata.org/entity/Q24675323

about

Vaccines for gonorrhea: can we rise to the challenge?Structure of the head of the Bartonella adhesin BadA Mapping of the Neisseria meningitidis NadA cell-binding site: relevance of predicted {alpha}-helices in the NH2-terminal and dimeric coiled-coil regions UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA Hib Vaccines: Past, Present, and Future Perspectives Meningococcal B Vaccination (4CMenB) in Infants and Toddlers How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease Role of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble Neisseria meningitidis adhesin A (rNadA) in human epithelial cells Complete fiber structures of complex trimeric autotransporter adhesins conserved in enterobacteria Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infection Protein Crystallography in Vaccine Research and Development Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations Neisseria meningitidis has two independent modes of recognizing its human receptor CEACAM1 Molecular Basis of Ligand-Dependent Regulation of NadR, the Transcriptional Repressor of Meningococcal Virulence Factor NadA Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil The soluble recombinant Neisseria meningitidis adhesin NadA(Δ351-405) stimulates human monocytes by binding to extracellular Hsp90 Rapid profiling of the antigen regions recognized by serum antibodies using massively parallel sequencing of antigen-specific libraries Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis.Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective.Cell invasion by Neisseria meningitidis requires a functional interplay between the focal adhesion kinase, Src and cortactin.Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae.A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements.Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model Virulence-associated trimeric autotransporters of Haemophilus parasuis are antigenic proteins expressed in vivo Review of meningococcal group B vaccines.Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.Microsatellite instability regulates transcription factor binding and gene expression Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa Apa is a trimeric autotransporter adhesin of Actinobacillus pleuropneumoniae responsible for autoagglutination and host cell adherence.

P2860

Q21131153-E4173FA9-5E75-446E-BBC4-E29677753B2F Q21131595-D30F5FF7-3D72-471D-9838-1B4014D748A8 Q24600500-63337944-C0A1-40AD-916B-18FB47C9FCDA Q24646909-61A3CD05-8D86-43D3-B6BB-482088BCCAA9 Q24672132-6DABF93C-5509-4E50-937F-F774DF4C70D5 Q26767144-16468866-01B5-4ECD-8DF3-4DC1143BAC4C Q26782285-F3BB1539-0711-4F32-8533-7C1DEB11FB51 Q26782340-D9C2BA4C-669A-46C7-B70E-8D3804A630B7 Q26995760-63DA51D0-1BCD-4D74-8B50-25F7F08800BF Q27335545-2EF959FC-726F-41D4-8CBF-60E016E69CB8 Q27675371-C7DB3E19-2DB3-4361-A584-5730C23E26B0 Q28080522-A2B41DFE-2B89-4D59-A19D-101CDB1DAAF5 Q28087528-22FE38E3-41BD-4627-B790-4E7527D545EB Q28241256-72D9BC3A-1954-4488-B00A-5C0134EB7F35 Q28476832-1954C9B2-AB76-418A-AFBE-63FE850FDDF9 Q28551548-E60762CE-981F-40F9-8EA1-A9EDFB5D1B0E Q28730284-9DFC65DB-A4B4-450A-8498-ECC76AF6D37A Q28731309-89C1DD1C-1D07-4527-8B5E-7ADD00849FDD Q28740303-6669A9B6-42D0-4868-9114-6B80C20C12EB Q29048193-F257CCAB-C4A7-4BF7-94CF-00942A405264 Q30150784-A30A80CD-AD77-494E-957F-789C9B5F85E5 Q30157650-D909F1E5-6049-4BF5-AFBF-C970BB2505EC Q30159832-CF41F0CD-AE48-4C41-809F-E84CB660CA1C Q30235072-190E3A22-0F8A-4E26-9797-A28E69678A94 Q30248749-896DE0F0-6D83-4331-827A-2FF0078ABB7C Q30354618-5BF95B9F-CC1F-47E9-9FEC-28C83E4EBA67 Q31071346-C0D35D73-1EDE-452C-B85E-365809A9F4E9 Q33278807-6A610121-4B00-46FF-A7D2-3DB727708C51 Q33348906-65D037F5-3BF9-4A01-BCAA-D48532B69FCC Q33521253-7C2093B7-B573-4A60-8EE0-C821C69ED937 Q33600936-D0C77BA4-DDC3-4B27-9C79-7F0CB6924327 Q33602953-52DCE4CC-1A96-48E4-9FA4-66D8486B863E Q33646169-13E18880-5651-4324-9873-CF8B1FB19842 Q33646965-FAA97066-1BA5-477B-BB06-48866B17C61F Q33703560-8AB0CAC8-CE7F-45A1-A4AC-872E243027E3 Q33792844-AC8EF70E-FF69-4338-A47D-6D210D1E45A8 Q33928490-49FDD5A0-3361-42C9-8B56-05F5BC75C79D Q34033132-B2266B79-1DF5-4901-B758-0497457EA932 Q34039044-290F75EF-F845-4ECE-BD7A-BB3030C75CF9 Q34092250-CF53B9FB-EB24-4E58-BE8D-3FEE182C738C

P2860

NadA, a novel vaccine candidate of Neisseria meningitidis

http://www.wikidata.org/entity/Q24675323

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

NadA, a novel vaccine candidate of Neisseria meningitidis

@ast

NadA, a novel vaccine candidate of Neisseria meningitidis

@en

NadA, a novel vaccine candidate of Neisseria meningitidis

@nl

type

label

NadA, a novel vaccine candidate of Neisseria meningitidis

@ast

NadA, a novel vaccine candidate of Neisseria meningitidis

@en

NadA, a novel vaccine candidate of Neisseria meningitidis

@nl

prefLabel

NadA, a novel vaccine candidate of Neisseria meningitidis

@ast

NadA, a novel vaccine candidate of Neisseria meningitidis

@en

NadA, a novel vaccine candidate of Neisseria meningitidis

@nl

P1433

Q24675323-E0ED4B1B-3768-4E6A-9ED4-A0C148CC1CD1

P1476

Q24675323-2FF20D9E-2193-4235-A584-4A3A595A438A

P2093

Q24675323-147501E1-973D-40E5-BE69-BD87007AF379

Q24675323-1792E0C9-D5EB-4593-BF66-B0CD99398C93

Q24675323-1EAA431D-1F50-434C-B3DF-4692D3561E08

Q24675323-2DDF6266-7E6E-4E29-8157-A293A5A6D4A0

Q24675323-4945959F-05E1-4054-BBEE-DE2EB8632BF4

Q24675323-53077745-09E2-4DFE-AFCD-1FFC65D4E265

Q24675323-6A3D4D2F-038F-4AC2-ACF4-8280D76A6959

Q24675323-7D077E55-A140-455A-BA12-1B08F038A77F

Q24675323-83D832DF-F288-4F29-90B0-618B48BB5A60

Q24675323-948B3DA1-F783-4F74-AA61-B9E267A0F3FF

P2860

Q24675323-13A3EF99-4E5E-4BCB-9438-AEDBA505E0E9

Q24675323-205C3A46-4A92-4BC5-B332-474AF8B6844D

Q24675323-20A5B090-6F6D-4280-BC8F-D6802ABE619B

Q24675323-2175C7AD-1C7F-4A00-9E2A-C5AD0DB3607A

Q24675323-24EE17F5-BA2F-44DC-9391-F355BB9F1BD7

Q24675323-2E1BE650-79F9-401F-8D6E-8EFF7F2B95A8

Q24675323-32AD5E3F-B5CC-4BCE-9F90-902DF88F1418

Q24675323-3686796C-2D68-42A3-B958-CA02F4AAF3EF

Q24675323-3BF69EE4-5E3D-4556-9298-4B4128629550

Q24675323-3FEBC4C5-A5D3-4570-8092-378384328633

P304

Q24675323-72595F5F-3E43-4EE5-9912-863CC8C98957

P31

Q24675323-DF3366E5-C0BB-456F-A1ED-92C9DB91F2AB

P3181

Q24675323-0A541C71-649C-4291-A118-AC4433BB5275

P356

Q24675323-653F137A-ECE8-4875-A2AC-72CA8A5A5400

P407

Q24675323-61D8D07C-1E88-40FA-8937-ABD09551D4E9

P433

Q24675323-2D6D1ABC-AB50-4FE5-B66A-C29949A10352

P478

Q24675323-8EA51E26-6CC5-483A-B00E-517E32BA5B73

P50

Q24675323-8040B2B4-393D-49FD-A863-555BCD351351

P577

Q24675323-F6162A53-AF29-4548-9262-D2261CD79B33

P698

Q24675323-A3822C3C-A39D-4CB7-9B96-1D0B7B35E256

P921

Q24675323-7C1BAEE9-7E21-4454-9A3C-7C82E5F936D8

P932

Q24675323-581A8514-7E13-4FCF-ABDE-CE1AF8D9BDE3

P3181

P356

P1433

Journal of Experimental Medicine

P1476

NadA, a novel vaccine candidate of Neisseria meningitidis

@en

P2093

Barbara Capecchi

http://www.w3.org/2001/XMLSchema#string

Beatrice Aricò

http://www.w3.org/2001/XMLSchema#string

Brunella Brunelli

http://www.w3.org/2001/XMLSchema#string

Dan M Granoff

http://www.w3.org/2001/XMLSchema#string

Dominique A Caugant

http://www.w3.org/2001/XMLSchema#string

Jeannette Adu-Bobie

http://www.w3.org/2001/XMLSchema#string

Laura Santini

http://www.w3.org/2001/XMLSchema#string

Mariagrazia Pizza

http://www.w3.org/2001/XMLSchema#string

Marirosa Mora

http://www.w3.org/2001/XMLSchema#string

Marzia Monica Giuliani

http://www.w3.org/2001/XMLSchema#string

P2860

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil

Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites

The virulence plasmid of Yersinia, an antihost genome

Coiled coils: new structures and new functions

Predicting coiled coils by use of pairwise residue correlations

Population genetics and molecular epidemiology of Neisseria meningitidis.

Insertion of Tn916 in Neisseria meningitidis resulting in loss of group B capsular polysaccharide.

P304

1445-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2145462

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20020407

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12045242

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria meningitidis

P932

2193550

http://www.w3.org/2001/XMLSchema#string